Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2018-10-29 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
2018年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "瑞康医药股份有限公司 2018 年第三季度报告全文" which translates to "Ruikang Pharmaceutical Co., Ltd. 2018 Third Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and management commentary on financial performance for the third quarter of 2018. The document includes comprehensive financial figures, comparisons to prior periods, and detailed notes on financial items. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The presence of quarterly financial statements and detailed analysis confirms this is an Interim / Quarterly Report rather than an earnings release or an announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2018
2018-10-29 Chinese
第三届董事会第十五次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 15th meeting of the third board of directors of Ruikang Medicine Co., Ltd. It details the approval of a proposal to issue asset-backed securities and the scheduling of an extraordinary shareholders' meeting. The document includes voting results and procedural details but does not contain financial statements or detailed financial analysis. It is a formal announcement of board decisions, specifically about financing plans and meeting arrangements. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short (1141 characters), and it is not a full report or financial statement, so it is not an Annual Report, Interim Report, or Capital/Financing Update report itself, but rather a board resolution announcement. Therefore, the correct classification is MANG with high confidence.
2018-10-22 Chinese
关于召开2018年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening a 2018 second extraordinary general meeting of shareholders for 瑞康医药股份有限公司. It includes information about the meeting time, location, voting procedures (both in-person and online), eligibility to attend, agenda items, and proxy authorization forms. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement and instructions for the shareholders' meeting. It fits the category of a Proxy Solicitation & Information Statement (PSI), as it provides materials sent to shareholders to inform and request votes for the meeting.
2018-10-22 Chinese
第三届监事会第十一次会议决议的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting regarding a proposed issuance of asset-backed securities. It includes details about the meeting date, voting results, and next steps, but does not contain financial statements or detailed financial data. The document is relatively short (881 characters) and serves as an official announcement of a board decision rather than a full report or detailed financial disclosure. It is not an annual or interim report, earnings release, or audit report. It is also not a regulatory filing or certification letter. The content fits best under Capital/Financing Update (CAP) because it discusses a financing proposal and related authorization.
2018-10-22 Chinese
关于转让公司及下属子公司部分应收账款发行资产支持证券的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to transfer certain accounts receivable to issue asset-backed securities. It details the transaction overview, parties involved, transaction targets, main content of the agreements, and the intended impact on the company. There are no financial statements or detailed financial performance data included. The document is relatively short (1718 characters) and serves as a formal disclosure of a financing activity rather than a full financial report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-10-22 Chinese
关于筹划2018年第一期员工持股计划的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (1084 characters) from a company about planning an employee stock ownership plan (员工持股计划) for 2018. It discusses the scope, stock source, participant range, and risk warnings related to the plan. There is no financial data, no detailed report, no financial statements, and no mention of an actual report being attached or published. The content is about a capital/financing update related to employee stock ownership plan arrangements, which fits the Capital/Financing Update (CAP) category. The document is not an annual report, interim report, or earnings release, nor is it a regulatory filing or announcement of a report publication. Therefore, the best classification is CAP with high confidence.
2018-10-22 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.